Avalon GloboCare Corp. ALBT
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Avalon GloboCare Corp. (ALBT)
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Key Insights
Critical company metrics and information
Latest Closing Price
$7.23Market Cap
$7.91 MillionPrice-Earnings Ratio
-0.10Total Outstanding Shares
1.09 Million SharesTotal Employees
5Dividend
No dividendIPO Date
February 22, 2016SIC Description
Biological Products, (no Disgnostic Substances)Primary Exchange
NASDAQType
Common StockHeadquarters
4400 route 9, Freehold, NJ, 07728Homepage
https://www.avalon-globocare.com
Historical Stock Splits
If you bought 150 shares of ALBT before January 5, 2023, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| October 28, 2024 | 1-for-15 (Reverse Split) |
| January 5, 2023 | 1-for-10 (Reverse Split) |
Cash Flow Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $822,988 |
| Net Cash Flow From Operating Activities, Continuing | $-1.89 Million |
| Net Cash Flow From Financing Activities | $2.72 Million |
| Net Cash Flow From Investing Activities, Continuing | $0 |
| Net Cash Flow | $823,625 |
| Exchange Gains/Losses | $637 |
Income Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations After Tax | $-1.68 Million |
| Basic Average Shares | $924,431 |
| Income/Loss From Continuing Operations Before Tax | $-1.68 Million |
| Costs And Expenses | $2.02 Million |
| Revenues | $345,159 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
Comprehensive Income
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $-1.68 Million |
| Other Comprehensive Income/Loss | $3,043 |
| Comprehensive Income/Loss Attributable To Parent | $-1.68 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $18.15 Million |
| Fixed Assets | $31,163 |
| Liabilities | $14.15 Million |
| Intangible Assets | $8.89 Million |
| Equity | $5.40 Million |
| Noncurrent Liabilities | $1.82 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Recent Headlines From The Web
Latest news, press releases, and media coverage about ALBT from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.